These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25642985)

  • 41. A ghrelin receptor and oxytocin receptor heterocomplex impairs oxytocin mediated signalling.
    Wallace Fitzsimons SE; Chruścicka B; Druelle C; Stamou P; Nally K; Dinan TG; Cryan JF; Schellekens H
    Neuropharmacology; 2019 Jul; 152():90-101. PubMed ID: 30582955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A plasmin-derived hexapeptide from the carboxyl end of osteocalcin counteracts oxytocin-mediated growth inhibition [corrected] of osteosarcoma cells.
    Novak JF; Judkins MB; Chernin MI; Cassoni P; Bussolati G; Nitche JA; Nishimoto SK
    Cancer Res; 2000 Jul; 60(13):3470-6. PubMed ID: 10910058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluorescent agonists and antagonists for vasopressin/oxytocin G protein-coupled receptors: usefulness in ligand screening assays and receptor studies.
    Mouillac B; Manning M; Durroux T
    Mini Rev Med Chem; 2008 Sep; 8(10):996-1005. PubMed ID: 18782052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis of a new pair of fluorescence resonance energy transfer donor and acceptor dyes and its use in a protease assay.
    Kainmüller EK; Ollé EP; Bannwarth W
    Chem Commun (Camb); 2005 Nov; (43):5459-61. PubMed ID: 16261246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of N-terminal glycosylation in the human oxytocin receptor.
    Kimura T; Makino Y; Bathgate R; Ivell R; Nobunaga T; Kubota Y; Kumazawa I; Saji F; Murata Y; Nishihara T; Hashimoto M; Kinoshita M
    Mol Hum Reprod; 1997 Nov; 3(11):957-63. PubMed ID: 9433921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crystal structure of the human oxytocin receptor.
    Waltenspühl Y; Schöppe J; Ehrenmann J; Kummer L; Plückthun A
    Sci Adv; 2020 Jul; 6(29):eabb5419. PubMed ID: 32832646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, synthesis, and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptors.
    Corbani M; Trueba M; Stoev S; Murat B; Mion J; Boulay V; Guillon G; Manning M
    J Med Chem; 2011 Apr; 54(8):2864-77. PubMed ID: 21428295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of dimeric and oligomeric complexes of the human oxytocin receptor by co-immunoprecipitation and bioluminescence resonance energy transfer.
    Devost D; Zingg HH
    J Mol Endocrinol; 2003 Dec; 31(3):461-71. PubMed ID: 14664707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Time-resolved fluorescence ligand binding for G protein-coupled receptors.
    Emami-Nemini A; Roux T; Leblay M; Bourrier E; Lamarque L; Trinquet E; Lohse MJ
    Nat Protoc; 2013; 8(7):1307-20. PubMed ID: 23764938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
    Oh KS; Lee S; Lee BH
    Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxytocin-receptor binding: why divalent metals are essential.
    Liu D; Seuthe AB; Ehrler OT; Zhang X; Wyttenbach T; Hsu JF; Bowers MT
    J Am Chem Soc; 2005 Feb; 127(7):2024-5. PubMed ID: 15713062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time resolved FRET strategy with fluorescent ligands to analyze receptor interactions in native tissues: application to GPCR oligomerization.
    Cottet M; Albizu L; Comps-Agrar L; Trinquet E; Pin JP; Mouillac B; Durroux T
    Methods Mol Biol; 2011; 746():373-87. PubMed ID: 21607869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A homogeneous single-label time-resolved fluorescence cAMP assay.
    Martikkala E; Rozwandowicz-Jansen A; Hänninen P; Petäjä-Repo U; Härmä H
    J Biomol Screen; 2011 Mar; 16(3):356-62. PubMed ID: 21343601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allosteric interactions between the oxytocin receptor and the β2-adrenergic receptor in the modulation of ERK1/2 activation are mediated by heterodimerization.
    Wrzal PK; Devost D; Pétrin D; Goupil E; Iorio-Morin C; Laporte SA; Zingg HH; Hébert TE
    Cell Signal; 2012 Jan; 24(1):342-50. PubMed ID: 21963428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A time-resolved fluorescence resonance energy transfer assay suitable for high-throughput screening for inhibitors of immunoglobulin E-receptor interactions.
    Kim B; Tarchevskaya SS; Eggel A; Vogel M; Jardetzky TS
    Anal Biochem; 2012 Dec; 431(2):84-9. PubMed ID: 22995065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bright, highly water-soluble triazacyclononane europium complexes to detect ligand binding with time-resolved FRET microscopy.
    Delbianco M; Sadovnikova V; Bourrier E; Mathis G; Lamarque L; Zwier JM; Parker D
    Angew Chem Int Ed Engl; 2014 Sep; 53(40):10718-22. PubMed ID: 25115848
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis, and biological application of fluorescent sensor molecules for cellular imaging.
    Kikuchi K
    Adv Biochem Eng Biotechnol; 2010; 119():63-78. PubMed ID: 19649586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fluorescent derivatives of AC-42 to probe bitopic orthosteric/allosteric binding mechanisms on muscarinic M1 receptors.
    Daval SB; Valant C; Bonnet D; Kellenberger E; Hibert M; Galzi JL; Ilien B
    J Med Chem; 2012 Mar; 55(5):2125-43. PubMed ID: 22329602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conversion of a non-selective adenosine receptor antagonist into A3-selective high affinity fluorescent probes using peptide-based linkers.
    Vernall AJ; Stoddart LA; Briddon SJ; Ng HW; Laughton CA; Doughty SW; Hill SJ; Kellam B
    Org Biomol Chem; 2013 Sep; 11(34):5673-82. PubMed ID: 23881285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A FRET-Based Assay for the Identification and Characterization of Cereblon Ligands.
    Boichenko I; Deiss S; Bär K; Hartmann MD; Hernandez Alvarez B
    J Med Chem; 2016 Jan; 59(2):770-4. PubMed ID: 26730808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.